Nature Communications (Jun 2021)

A meta-analysis of epigenome-wide association studies in Alzheimer’s disease highlights novel differentially methylated loci across cortex

  • Rebecca G. Smith,
  • Ehsan Pishva,
  • Gemma Shireby,
  • Adam R. Smith,
  • Janou A. Y. Roubroeks,
  • Eilis Hannon,
  • Gregory Wheildon,
  • Diego Mastroeni,
  • Gilles Gasparoni,
  • Matthias Riemenschneider,
  • Armin Giese,
  • Andrew J. Sharp,
  • Leonard Schalkwyk,
  • Vahram Haroutunian,
  • Wolfgang Viechtbauer,
  • Daniel L. A. van den Hove,
  • Michael Weedon,
  • Danielle Brokaw,
  • Paul T. Francis,
  • Alan J. Thomas,
  • Seth Love,
  • Kevin Morgan,
  • Jörn Walter,
  • Paul D. Coleman,
  • David A. Bennett,
  • Philip L. De Jager,
  • Jonathan Mill,
  • Katie Lunnon

DOI
https://doi.org/10.1038/s41467-021-23243-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Although epigenome-wide association studies of Alzheimer’s disease have highlighted neuropathology-associated DNA methylation differences, previous studies have been limited in sample size and brain region used. Here, the authors combine data from six DNA methylomic studies of Alzheimer’s disease (N = 1453 unique individuals) to identify differentially methylated loci across cortex.